What Causes Irregular Periods in Your 40s? Perimenopause Explained

Why Periods Become Irregular in Your 40s

Ovarian reserve declines steadily from the mid-30s onward, and by the early 40s that decline accelerates enough to disrupt the hormonal feedback loop that governs the menstrual cycle. Estradiol production becomes erratic rather than steadily rising and falling in predictable waves, and the pituitary gland compensates by releasing more follicle-stimulating hormone (FSH). The result is cycles that are longer, shorter, heavier, lighter, or simply absent some months.

The American College of Obstetricians and Gynecologists (ACOG) describes perimenopause as beginning "when ovarian function starts to decline and ending 12 months after the final menstrual period" [1]. That transition typically starts in the mid-40s, though it can begin as early as the late 30s.

The Role of Declining Ovarian Reserve

Each month, a cohort of follicles is recruited to develop in the ovary. As women age, the pool of remaining follicles shrinks. Fewer high-quality follicles mean less consistent estradiol output. Some cycles may be anovulatory, meaning no egg is released at all, which removes the normal progesterone surge from the luteal phase [2]. Without adequate progesterone, the uterine lining may shed unpredictably or build up and then shed heavily.

Research published in the journal Menopause found that the variability of cycle length, specifically a 7-day or greater difference from normal length in two of ten cycles, is among the earliest measurable signs of the menopausal transition [3].

FSH and the Hormonal Feedback Loop

FSH rises because the pituitary is trying to stimulate follicles that are becoming less responsive. A single elevated FSH reading is not diagnostic of perimenopause on its own because levels fluctuate dramatically cycle to cycle. The Menopause Society's 2023 Position Statement notes that FSH above 25 IU/L on two separate measurements, combined with menstrual irregularity, supports a clinical diagnosis of perimenopause but does not replace it [4].

Estradiol levels during perimenopause can spike to supraphysiologic highs in some cycles (driving breast tenderness and heavy bleeding) and then drop sharply in others (causing hot flashes and vaginal dryness). This variability, not simply low estrogen, explains why symptoms during perimenopause are often more unpredictable than those after menopause.

What "Irregular" Actually Looks Like

Perimenopause-related irregularity takes several distinct forms:

• Shorter cycles. Early perimenopause often brings cycles of 21 to 24 days instead of the typical 28 to 35, because the follicular phase shortens.
• Skipped cycles. Anovulatory months mean no period at all, then a heavier-than-normal bleed when ovulation eventually occurs.
• Prolonged or heavy bleeding. Unopposed estrogen from anovulatory cycles builds the endometrial lining, producing heavier and longer periods.
• Spotting between periods. Erratic estrogen drops mid-cycle can trigger breakthrough bleeding.

How Long Does Perimenopause Last?

Perimenopause lasts an average of 4 to 8 years, though the range is wide. A longitudinal analysis from the Study of Women's Health Across the Nation (SWAN), which followed 3,302 women across multiple ethnic groups, found that the median duration of the late menopausal transition was 1 to 3 years, but the full perimenopausal period from first cycle irregularity to the final period averaged 7.4 years [5].

STRAW+10 Staging System

Clinicians use the Stages of Reproductive Aging Workshop (STRAW+10) framework to define where a woman sits in the transition. STRAW+10 divides the menopausal transition into two stages:

• Stage -2 (early transition). Cycle length varies by 7 or more days from normal in two consecutive cycles. FSH may begin to rise intermittently.
• Stage -1 (late transition). Two or more skipped cycles and at least one interval of 60 days or longer between periods. FSH is consistently elevated above 25 IU/L.

The STRAW+10 criteria were published in Climacteric and remain the standard staging tool for clinical and research use [6].

Race and Ethnicity Affect Duration

SWAN data showed that Black women experienced a longer menopausal transition (median 8.5 years) compared to white women (6.5 years), and Hispanic and Chinese women had intermediate durations [5]. These differences are not fully explained by socioeconomic or lifestyle factors, suggesting biological contributors that are still being studied.

Other Causes of Irregular Periods in Your 40s

Perimenopause is the most common explanation for menstrual changes in the 40s, but not the only one. Before attributing cycle changes to perimenopause, clinicians typically rule out:

Thyroid Dysfunction

Both hypothyroidism and hyperthyroidism disrupt the hypothalamic-pituitary-gonadal axis. The American Thyroid Association estimates that thyroid disease affects up to 20% of women over 40 [7]. A TSH is inexpensive and should be part of any workup for new menstrual irregularity.

Polycystic Ovary Syndrome (PCOS)

PCOS does not disappear at 40. Women who had irregular cycles from PCOS in their 20s may find the pattern worsens as ovarian reserve declines and the two conditions overlap. A 2021 review in the Journal of Clinical Endocrinology and Metabolism confirmed that distinguishing PCOS-related anovulation from perimenopause often requires clinical history plus anti-Mullerian hormone (AMH) testing [8].

Hyperprolactinemia and Stress

Elevated prolactin from a pituitary adenoma, medications, or chronic stress suppresses GnRH pulsatility and can interrupt ovulation at any age. A serum prolactin level rules this out quickly.

Endometrial Pathology

Polyps, fibroids, and endometrial hyperplasia all cause irregular or heavy bleeding and are more common after 40. The American College of Radiology recommends transvaginal ultrasound as the first imaging step for abnormal uterine bleeding in women over 45, with endometrial biopsy if the endometrial stripe exceeds 4 mm in a postmenopausal woman or if risk factors for hyperplasia are present [9].

Symptoms That Accompany Irregular Periods in Perimenopause

Cycle changes rarely arrive alone. The most commonly reported co-occurring symptoms are:

• Vasomotor symptoms. Hot flashes and night sweats affect roughly 75% of perimenopausal women [4]. They result from estrogen-related changes in the hypothalamic thermoregulatory set point.
• Sleep disruption. Night sweats interrupt sleep architecture, but estrogen receptors in the brain also directly influence sleep quality independent of sweating.
• Mood changes. The perimenopausal years carry a 2- to 4-fold increased risk of a first depressive episode compared with premenopausal years, according to a prospective study published in Archives of General Psychiatry [10].
• Genitourinary symptoms. Declining estrogen thins vaginal and urethral epithelium, causing dryness, dyspareunia, and increased urinary urgency.
• Cognitive changes. Many women report word-finding difficulty and memory lapses. A study in the journal Menopause found that verbal memory decline during perimenopause is measurable but typically modest and partially reversible after the transition [11].

How Perimenopause Is Diagnosed

Perimenopause is a clinical diagnosis in women over 45 with characteristic symptoms and menstrual changes. No single lab test confirms it.

Lab Tests Worth Ordering

• FSH. Two readings above 25 IU/L on separate cycles support the diagnosis. One reading is insufficient because of cycle-to-cycle variability.
• Estradiol. Erratic but does not reliably distinguish perimenopause from other causes of irregularity on a single draw.
• AMH. Low AMH reflects diminished ovarian reserve and is a more stable marker than FSH. A 2020 meta-analysis in Human Reproduction found AMH below 0.7 ng/mL predicted the menopausal transition within 5 years with 73% sensitivity [12].
• TSH. Rules out thyroid disease.
• Beta-hCG. Pregnancy must be excluded in any woman still having periods, regardless of age.

When to Get an Endometrial Biopsy

The American Cancer Society recommends evaluation for endometrial cancer in any woman over 40 with unexpected uterine bleeding [13]. Endometrial biopsy is indicated when:

• Bleeding episodes last longer than 10 days
• Cycles occur more frequently than every 21 days
• Postmenopausal bleeding occurs (any bleeding after 12 consecutive period-free months)
• Transvaginal ultrasound shows an endometrial stripe above 4 mm post-menopause

Treatment Options for Perimenopause-Related Irregular Periods and Symptoms

Managing perimenopause involves addressing both cycle regulation and symptom relief. The approach depends on symptom severity, contraceptive needs, and individual health history.

Menopausal Hormone Therapy (MHT/HRT)

Menopausal hormone therapy, combining estrogen with a progestogen (or progestogen alone in women who have had a hysterectomy), is the most effective treatment for vasomotor symptoms and genitourinary changes. The Menopause Society's 2023 Position Statement states: "For women aged younger than 60 years or within 10 years of menopause onset, the benefits of MHT outweigh the risks for the treatment of bothersome vasomotor symptoms in the absence of contraindications" [4].

Common regimens during perimenopause include:

• Low-dose combined oral contraceptives (COCs). A 20 mcg ethinyl estradiol pill such as Loestrin 1/20 provides cycle regulation, contraception, and symptom control. The FDA approves COCs through natural menopause in non-smoking women without cardiovascular contraindications [14].
• Transdermal estradiol plus micronized progesterone. A patch delivering 0.05 mg/day estradiol combined with oral micronized progesterone 200 mg for 12 days per month is one common cyclic MHT protocol. Transdermal delivery bypasses hepatic first-pass metabolism and carries a lower venous thromboembolism risk than oral estradiol, as demonstrated in the E3N cohort study (N=80,308) [15].
• Levonorgestrel IUD (Mirena 52 mg). Provides endometrial protection as the progestogen component of MHT, controls heavy bleeding, and offers contraception. Approved by the FDA for up to 8 years [16].

Hormonal Contraceptives for Cycle Regulation

Low-dose COCs or the levonorgestrel IUD are often the first choice for perimenopausal women who also need contraception. Pregnancy remains possible until 12 consecutive period-free months, even as cycles become irregular. The CDC's U.S. Medical Eligibility Criteria for Contraceptive Use (US MEC) classifies COC use in women over 40 without cardiovascular risk factors as category 2 (benefits generally outweigh risks) [17].

Non-Hormonal Options

For women who cannot or prefer not to use hormones:

• Fezolinetant (Veozah) 45 mg daily. An FDA-approved neurokinin 3 receptor antagonist that reduces hot flash frequency without hormonal activity. The SKYLIGHT 4 trial (N=491, 52 weeks) showed a 51% reduction in moderate-to-severe hot flash frequency vs. 20% for placebo (P<0.001) [18].
• Paroxetine 7.5 mg (Brisdelle). The only FDA-approved SSRI for vasomotor symptoms. Reduces hot flash frequency by approximately 33% to 67% in clinical trials [19].
• Cognitive behavioral therapy (CBT). A randomized trial published in Menopause (N=150) found that a structured 4-session CBT program reduced hot flash problem rating by 46% vs. 17% for the control group at 6 weeks [20].

The HealthRX clinical team uses a three-tier decision framework for perimenopausal management based on symptom burden, contraceptive need, and cardiovascular risk profile. Tier 1 applies COCs or the levonorgestrel IUD for women needing contraception with mild-to-moderate symptoms. Tier 2 moves to transdermal MHT plus micronized progesterone when contraception is no longer required or when COC cardiovascular risk is elevated. Tier 3 adds fezolinetant or an SSRI for women with MHT contraindications (active breast cancer, unexplained vaginal bleeding, or personal history of VTE on oral therapy).

Managing Heavy Perimenopausal Bleeding

Heavy menstrual bleeding (HMB) in perimenopause is defined as blood loss exceeding 80 mL per cycle or bleeding lasting more than 7 days. Options include:

• Levonorgestrel IUD. Reduces menstrual blood loss by 71% to 96% at 12 months in randomized trials [21].
• Tranexamic acid 1.3 g orally three times daily for up to 5 days during menstruation. Non-hormonal and FDA-approved specifically for HMB [22].
• NSAIDs (naproxen 500 mg twice daily during menses). Reduce prostaglandin-driven bleeding by approximately 20% to 30% [21].
• Endometrial ablation. A minimally invasive office procedure that destroys the uterine lining. Effective for 80% to 90% of women at 12 months but does not treat vasomotor or other systemic symptoms [23].

When to See a Clinician Urgently

Most perimenopausal cycle changes are benign, but certain patterns require prompt evaluation:

• Any bleeding after 12 consecutive period-free months (postmenopausal bleeding).
• Cycles shorter than 21 days recurring over 3 months.
• Bleeding that soaks more than one pad or tampon per hour for 2 or more consecutive hours.
• Intermenstrual bleeding that is new and persists beyond one cycle.
• Any bleeding in a woman with risk factors for endometrial cancer (obesity, diabetes, unopposed estrogen exposure, PCOS, or Lynch syndrome).

ACOG Practice Bulletin No. 128 states that "endometrial sampling is indicated in women 45 and older with abnormal uterine bleeding, and in women younger than 45 with risk factors" [9]. Delaying this evaluation in women who meet criteria is the most common missed opportunity in perimenopausal care.

Lifestyle Factors That Influence Perimenopausal Symptoms

Hormonal changes drive perimenopause, but several modifiable factors affect symptom severity.

Body Weight

Adipose tissue converts androgens to estrone, meaning women with higher body mass index may experience more irregular cycles but fewer vasomotor symptoms. The tradeoff is increased risk of endometrial hyperplasia from unopposed estrogen. The SWAN study found that women with a BMI <25 reported more severe hot flashes than those with BMI above 30 [24].

Smoking

Smokers reach menopause 1 to 2 years earlier than non-smokers, according to a meta-analysis of 11 prospective cohort studies published in Tobacco Control [25]. Smoking also reduces the efficacy of transdermal estrogen and is a relative contraindication to combined oral contraceptives.

Physical Activity

Moderate aerobic exercise, 150 minutes per week per CDC guidelines, does not significantly reduce hot flash frequency in randomized trials, but it does improve sleep quality, reduce depressive symptoms, and lower cardiovascular risk during the transition [26].

Alcohol

Each additional daily alcoholic drink raises circulating estradiol by approximately 7% in premenopausal women, according to data from the Nurses' Health Study II [27]. Higher estradiol from alcohol may worsen breast tenderness and irregular bleeding.